Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial (Q28247190)
Jump to navigation
Jump to search
scientific article (publication date: August 1997)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial |
scientific article (publication date: August 1997) |
Statements
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial (English)
M Lai
S Hodgkinson
F Barkhof
D H Miller
I F Moseley
A J Thompson
P Rudge
J G McLeod
H J Adèr
1 August 1997
Identifiers
2 references
2 references